About the Activity
This activity has been developed as part of the E-Learning Series and is posted on cancernetwork.com. It will be used to help physicians with their (re)certification or as a clinical review.
This activity has been developed and approved under the direction of Beam Institute.
Activity Learning Objectives
(a) Provide thought provoking board type questions that prepare the oncologist and fellow for the board examination, and for treating patients
(b) Assist the non-recertifying clinician to better understand the current standards of care as well as the latest advances in the treatment of lung cancer
(c) To design thought provoking questions covering the adjuvant and metastatic treatment of lung cancer
(d) Provide oncologists review questions that will incorporate the latest results of clinical trials
Target Audience
This activity targets physicians in the fields of oncology and hematology.
Accreditation
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Beam Institute and The Oncology Group. Beam Institute is accredited by the ACCME to provide continuing medical education for physicians.
Continuing Education Credit
AMA PRA Category 1 Credit™
The Beam Institute designates this educational activity for a maximum of 3 AMA PRA Category 1 Credit(s)™. Physicians should only claim the credit commensurate with the extent of their participation in the activity.
Compliance Statement
This activity is an independent educational activity under the direction of Beam Institute. The activity was planned and implemented in accordance with the Essential Areas and policies of the ACCME, the Ethical Opinions/Guidelines of the AMA, the FDA, the OIG, and the PhRMA Code on Interactions with Healthcare Professionals, thus assuring the highest degree of independence, fair balance, scientific rigor, and objectivity.
However, Beam Institute, the Grantor, and CMPMedica shall in no way be liable for the currency of information or for any errors, omissions, or inaccuracies in the activity. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Activity participants are encouraged to refer to primary references or full prescribing information resources. The opinions and recommendations presented herein are those of the author(s) and do not necessarily reflect the views of the provider or producer.
Financial Disclosures
Dr. Sandler serves on the speakers' bureau for Genentech; he is also a consultant and receives research support for Amgen, Bayer, Genentech and Pfizer. Dr. Langer is a member of the speakers’ bureau for Bristol-Myers Squibb, Sanofi-Aventis, Eli Lilly, OrthoBiotech and Genentech; he is a consultant for Bristol-Myers Squibb, ImClone, Sanofi-Aventis, Pharmacia, Intrabiotics, GlaxoSmithKline, Pharmacyclics, Amgen, AstraZeneca, Novartis, Genentech, Bayer and Millenium. He also receives grants/research support from Bristol-Myers Squibb, Pharmacia, Eli Lilly, Schering-Plough Research Institute, Sanofi-Aventis, Amgen, Cell Therapeutics Inc., OrthoBiotech, Celgene, Vertex, Genentech, AstraZeneca, Pfizer, Active Biotech, Medimmune and Millenium.
Copyright
Copyrights owned by Beam Institute, a division of CME LLC. Copyright 2007 CME LLC. All rights reserved.
Contact Information
We would like to hear your comments regarding this or other activities provided by Beam Institute. In addition, suggestions for future activities are welcome. Contact us at:
Address:
Director of Continuing Education
Beam Institute
11 West 19th Street, 3rd Floor
New York, NY 10011-4280
Phone: 888-618-5781
Fax: 212-600-3050
e-mail: beaminstitute@cmp.com
